When Mitochondria Break vs When They Slow Down
- Healing_ Passion
- Apr 2
- 3 min read
Why we need both structural and functional models of dysfunction
We often hear the phrase “mitochondrial dysfunction” as if it’s one thing.
But what if it’s not?
What if mitochondria don’t just break—they first struggle, slow down, and only later begin to fall apart?
A recent review——offers an important piece of this puzzle. It proposes that a special mitochondrial lipid called cardiolipin may hold the key to understanding many age-related diseases.
But it also reveals something equally important:we may be missing half the story.
The Structural Model: When the System Falls Apart
The review focuses on cardiolipin, a unique lipid that acts like the “glue” of the mitochondrial inner membrane.
It helps:
Organize the electron transport chain
Maintain membrane curvature (cristae)
Support energy production
Under stress—especially oxidative stress—this lipid gets remodeled by an enzyme called ALCAT1.
And this is where things go wrong.
Cardiolipin becomes:
More fragile
More prone to oxidation
Less able to support mitochondrial structure
This triggers a vicious cycle:
Oxidation → membrane damage → more oxidation
Eventually, mitochondria:
Lose their shape
Leak signals like mtDNA
Fail to produce energy efficiently
In simple terms:The hardware is damaged.
This model is powerful. It explains:
Aging-related diseases
Neurodegeneration
Heart failure
Metabolic disorders
It even suggests that many of these conditions may be different expressions of the same underlying mitochondrial problem.
But What If Mitochondria Are Still Intact… and Just Overloaded?
Here’s the missing piece.
Mitochondria don’t suddenly break.
Before structural damage appears, they often enter a state of functional strain.
Imagine a highway:
Cars keep entering
But the exit lane is too narrow
Traffic builds up.
Nothing is broken—but nothing moves well.
This is what we call a throughput problem.
Inside mitochondria, this looks like:
Too many reducing equivalents (NADH)
Not enough capacity in the electron transport chain
Slowed electron flow
Reduced ATP production
In simple terms: The system is congested—even if the structure looks normal.
The ERM Perspective: A Continuum, Not a Category
This is where the Exposure-Related Malnutrition (ERM) framework comes in.
Instead of asking:“Is the mitochondria functional or dysfunctional?”
ERM asks: “Where along the continuum is it?”
Phase 1 — Functional Constraint (early, reversible)
Redox imbalance (↑ NADH/NAD⁺)
Slowed oxidative flux
ATP becomes limited
Substrates get diverted (fat storage, lactate production)
You may feel:
Fatigue
Brain fog
Reduced resilience
But nothing looks obviously “broken” yet.
Phase 2 — Structural Remodeling (progressive)
Persistent congestion → increased oxidative stress
Cardiolipin gets remodeled (as described in the review)
Membrane integrity declines
Now structure begins to change.
Phase 3 — Structural Failure (late stage)
Cristae collapse
mtDNA damage
Mitophagy dysfunction
Loss of mitochondrial capacity
This is where disease becomes visible.
A Simple Way to See It
Structural model (cardiolipin): explains how mitochondria break
Functional model (throughput): explains why they struggle before breaking
ERM integrates both:
Mitochondrial dysfunction is not a single event—it is a progression from functional congestion to structural damage to systemic disease.
Why This Changes Everything
If we only focus on structural damage:
We intervene late
When the system is already failing
But if we recognize functional constraint:
We can act earlier
When recovery is still possible
This is a much more hopeful message.
Not:
“Your mitochondria are damaged.”
But:
“Your system may be overwhelmed—and with the right support, it can recover.”
The Takeaway
The cardiolipin–ALCAT1 model gives us a powerful lens into mitochondrial structure and damage.
But to fully understand health, aging, and chronic disease, we also need to see:
How energy flows
Where it gets bottlenecked
And when the system begins to compensate
Because long before mitochondria break…
They slow down.
And that’s where the story—and the opportunity—begins.
Zhang, J., & Shi, Y. (2022). In search of the holy grail: Toward a unified hypothesis on mitochondrial dysfunction in age-related diseases. Cells, 11(12), 1906. https://doi.org/10.3390/cells11121906





Comments